97 related articles for article (PubMed ID: 26363974)
1. Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model.
Li Q; Zhang X
Int Immunopharmacol; 2015 Dec; 29(2):818-823. PubMed ID: 26363974
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice.
Álvarez-Pérez B; Homs J; Bosch-Mola M; Puig T; Reina F; Verdú E; Boadas-Vaello P
Eur J Pain; 2016 Mar; 20(3):341-52. PubMed ID: 25913854
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells.
Liu W; Fan JB; Xu DW; Zhang J; Cui ZM
Exp Biol Med (Maywood); 2016 Mar; 241(6):658-66. PubMed ID: 26748399
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia.
Cheng-Chung Wei J; Huang HC; Chen WJ; Huang CN; Peng CH; Lin CL
Eur J Pharmacol; 2016 Jan; 770():16-24. PubMed ID: 26643169
[TBL] [Abstract][Full Text] [Related]
7. The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain.
El Mouedden M; Meert TF
Pharmacol Biochem Behav; 2007 May; 87(1):30-40. PubMed ID: 17521715
[TBL] [Abstract][Full Text] [Related]
8. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.
Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M
Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Ahn HY; Xu Y; Davidge ST
Life Sci; 2008 Apr; 82(17-18):964-8. PubMed ID: 18397796
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model.
Gu X; Zheng Y; Ren B; Zhang R; Mei F; Zhang J; Ma Z
Mol Pain; 2010 Oct; 6():64. PubMed ID: 20923560
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-Gallate Antihyperalgesic Effect Associates With Reduced CX3CL1 Chemokine Expression in Spinal Cord.
Bosch-Mola M; Homs J; Álvarez-Pérez B; Puig T; Reina F; Verdú E; Boadas-Vaello P
Phytother Res; 2017 Feb; 31(2):340-344. PubMed ID: 27896922
[TBL] [Abstract][Full Text] [Related]
12. Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats.
Kuang X; Huang Y; Gu HF; Zu XY; Zou WY; Song ZB; Guo QL
Eur J Pharmacol; 2012 Feb; 676(1-3):51-6. PubMed ID: 22173123
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Tipoe GL; Leung TM; Liong EC; Lau TY; Fung ML; Nanji AA
Toxicology; 2010 Jun; 273(1-3):45-52. PubMed ID: 20438794
[TBL] [Abstract][Full Text] [Related]
14. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.
Fujiki H; Suganuma M; Okabe S; Sueoka E; Suga K; Imai K; Nakachi K
Cancer Detect Prev; 2000; 24(1):91-9. PubMed ID: 10757128
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.
Renno WM; Al-Khaledi G; Mousa A; Karam SM; Abul H; Asfar S
Neuropharmacology; 2014 Feb; 77():100-19. PubMed ID: 24071567
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
[TBL] [Abstract][Full Text] [Related]
17. Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model.
Choi JI; Kim WM; Lee HG; Kim YO; Yoon MH
Neurosci Lett; 2012 Feb; 510(1):53-7. PubMed ID: 22249118
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin-3-gallate alleviates Porphyromonas gingivalis-induced periodontitis in mice.
Cai Y; Chen Z; Liu H; Xuan Y; Wang X; Luan Q
Int Immunopharmacol; 2015 Dec; 29(2):839-845. PubMed ID: 26359545
[TBL] [Abstract][Full Text] [Related]
19. The effect of orally administered epigallocatechin-3-gallate on ligature-induced periodontitis in rats.
Cho AR; Kim JH; Lee DE; Lee JS; Jung UW; Bak EJ; Yoo YJ; Chung WG; Choi SH
J Periodontal Res; 2013 Dec; 48(6):781-9. PubMed ID: 23581513
[TBL] [Abstract][Full Text] [Related]
20. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms.
Liu S; Yang J; Wang L; Jiang M; Qiu Q; Ma Z; Liu L; Li C; Ren C; Zhou J; Li W
Brain Res; 2010 Jul; 1346():213-23. PubMed ID: 20478276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
